Lyra Therapeutics, Inc.

The current price of LYRA is 5.21 USD — it has increased by 0.39% in the past 24 hours.

Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Lyra Therapeutics, Inc. stocks are traded under the ticker LYRA.

Lyra Therapeutics, Inc. is going to release the next earnings report on May 7, 2024. Keep track of upcoming events with our Earnings Calendar.

LYRA stock is 4.14% volatile and has beta coefficient of 0.86. Check out the list of the most volatile stocks — is Lyra Therapeutics, Inc. there?

One year price forecast for Lyra Therapeutics, Inc. has a max estimate of 15.00 USD and a min estimate of 10.00 USD.

LYRA earnings for the last quarter are −0.27 USD per share, whereas the estimation was −0.32 USD resulting in a 14.94% surprise. The estimated earnings for the next quarter are −0.32 USD per share. See more details about Lyra Therapeutics, Inc. earnings.

Lyra Therapeutics, Inc. revenue for the last quarter amounts to ‪544.00 K‬ USD despite the estimated figure of ‪371.60 K‬ USD. In the next quarter revenue is expected to reach ‪388.80 K‬ USD.

Yes, you can track Lyra Therapeutics, Inc. financials in yearly and quarterly reports right on TradingView.

LYRA net income for the last quarter is ‪−15.16 M‬ USD, while the quarter before that showed ‪−15.65 M‬ USD of net income which accounts for 3.16% change. Track more Lyra Therapeutics, Inc. financial stats to get the full picture.

Today Lyra Therapeutics, Inc. has the market capitalization of ‪311.26 M‬, it has decreased by 0.57% over the last week.

No, LYRA doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.

Like other stocks, LYRA shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Lyra Therapeutics, Inc. stock right from TradingView charts — choose your broker and connect to your account.

LYRA reached its all-time high on May 1, 2020 with the price of 22.00 USD, and its all-time low was 1.86 USD and was reached on Mar 27, 2023.
See other stocks reaching their highest and lowest prices.

As of Apr 23, 2024, the company has 88.00 employees. See our rating of the largest employees — is Lyra Therapeutics, Inc. on this list?

Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Lyra Therapeutics, Inc. technincal analysis shows the sell today, and its 1 week rating is neutral. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Lyra Therapeutics, Inc. stock shows the buy signal. See more of Lyra Therapeutics, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.

We've gathered analysts' opinions on Lyra Therapeutics, Inc. future price: according to them, LYRA price has a max estimate of 15.00 USD and a min estimate of 10.00 USD. Read a more detailed Lyra Therapeutics, Inc. forecast: see what analysts think of Lyra Therapeutics, Inc. and suggest that you do with its stocks.

EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Lyra Therapeutics, Inc. EBITDA is ‪−65.25 M‬ USD, and current EBITDA margin is ‪−4.19 K‬%. See more stats in Lyra Therapeutics, Inc. financial statements.